Pushing boundaries in Medical Affairs.
An evolving healthcare landscape will continue to bring new challenges for medical affairs. But with a more customized and proactive strategy, supported with large-scale data analytics and innovative approaches, we can demonstrate the value of medical affairs and enhance the impact of your strategic imperatives.
Addressing client challenges.
Leveraging medical affairs earlier in clinical development
Early involvement of medical affairs can not only be valuable to R&D but also allows for more confident indication pathway decisions.
Quantifying the impact and value of medical affairs
With the right tools, methods, and metrics you can be better equipped to demonstrate impact and value to your teams.
Advancing your strategy with artificial intelligence (AI)
We can help you enhance your strategies by leveraging AI to generate more comprehensive insights.
Our latest thinking.
-
Read more
Leveraging large language models with RWE to generate more comprehensive insights in Medical Affairs
LLMs are being leveraged in healthcare to analyze real-world data that may unlock valuable insights on improving patient outcomes.
-
Read more
Leading world-class Medical Affairs into the future: Insights from Putnam’s Medical Affairs Leadership Council (Spring 2024)
We recently reconvened our Medical Affairs Leadership Council, discussing top of mind topics with leaders.
-
Read more
Learnings from the World EPA Congress for Medical Affairs
This year at the World EPA Congress in Amsterdam, Putnam participated in the meeting and identified areas of interest to medical affairs including...
-
Read more
Learnings from MAPS Americas 2024
Putnam experts share key learnings coming out of MAPS Americas 2024
Watch our latest webinar in partnership with MAPS on-demand.
View thought-provoking webinar in partnership with the Medical Affairs Professional Society (MAPS): “Optimizing Clinical Development Plans Through Earlier Integration of Medical Affairs” featuring Lori Klein, PharmD, Partner, Medical & Scientific Affairs Practice Lead and industry experts.
Medical Affairs Leadership Council.
The Medical Affairs Leadership Council brings together Chief Medical Officers and Heads of Medical Affairs to discuss current issues facing the industry, spark innovative solutions, and advance the potential of medical affairs.
Case studies.
-
Read more
Precision medicine biomarker planning
A top biopharma client was in early-stage clinical development of an asset that showed efficacy in all-comers with the target disease, but even...
-
Read more
Rare respiratory claims data analysis
A top biopharma client wanted to understand diagnosis and treatment patterns for a rare respiratory disease only recently associated as a sequela....
-
Read more
Rare disease research consortium guidance on AI diagnostic tools
A rare disease research consortium sought to identify barriers to adoption of AI-enabled, point-of-care diagnostic decision support tools..
We're part of Inizio Advisory. See how we're collectively helping clients Transform with Impact.
Catch us in person.
May 6-8th
We’re joining MASS East as a sponsor and speaker. Lori Klein will be leading the discussion, “Leveraging Foundational Analytics Platforms to Demonstrate Medical Affairs Impact” on May 7th at 11:45am EST.
Catch us in person.
May 12-14th
As a partner circle member, we’ll be sharing a presentation at MAPS EMEA in partnership with an industry expert from Pfizer, “Unlocking the True Potential: How Can We Best Quantify the Impact and Value of Medical Affairs?
